Speech-Language Pathologists in Amityville, NY Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Mrs. Rita Russo, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Elgin Rd, Amityville, NY 11701 Phone: 516-982-5648

Diane Marie Parker Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 Prospect St, Amityville, NY 11701 Phone: 631-264-7809

Suzanne H. Domni Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Cedar St, Amityville, NY 11701 Phone: 631-598-4808    Fax: 631-598-4808

Mrs. Francine Ann John, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Park Ave, Amityville, NY 11701 Phone: 631-691-2874

Mrs. Jaime L Mangan, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Kent Pl, Amityville, NY 11701 Phone: 631-532-6973

Mrs. Mary Kate Mills, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 34 Riverleigh Pl, Amityville, NY 11701 Phone: 631-608-0349

Kristyne Michelle Fenton, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Louden Ave, Amityville, NY 11701 Phone: 631-608-5632

Mrs. Caryn F Oliver, M.S.,CCC,SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 Carleton Ave, Amityville, NY 11701 Phone: 631-691-6560

News Archive

Will the Ebola crisis lead to improved global health security?

Unprecedented in both its impact and scale, the Ebola virus outbreak in West Africa has led to a renewed interest in the issue of global health security. How is global health security defined?..

CPRIT announces new grants to support variety of cancer-fighting research projects in Texas

The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-fighting efforts in Texas. These new awards bring the total tally of funded grants to 502, amounting to nearly $841 million since the Institute opened its doors in 2009.

AcelRx commences dosing in second ARX-01 Phase 3 clinical trial for acute post-operative pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported dosing of the first patient in the second of three planned Phase 3 studies that will form the basis of a planned New Drug Application for the Sufentanil NanoTab PCA System, ARX-01.

Scientists join patients to address Friedreich's Ataxia

The Spanish Federation of Ataxia (FEDAES)—in representation of the GENEFA Platform for a Friedreich's Ataxia cure—, the Babel Family association for biomedical research into Friedreich's Ataxia, the "Centro de Biología Molecular Severo Ochoa" (CMBSO), and the Institute for Research in Biomedicine (IRB Barcelona) have signed an agreement through which these patients' associations will fund, by means of donations, a 3-year research project addressing Friedreich's Ataxia.

Read more Medical News

› Verified 1 days ago